We assessed the validity of clinical diagnosis of topography (CDT) and etiology (CDE) in 100 consecutive patients who were examined within 12 h of stroke onset by a stroke team (1 neurologist with interest in stroke, 1 fellow, 1 resident). The team established a first- and a second-choice CDT (among 28 possibilities) and CDE (among 11 possibilities). CDT was compared with CT and MRI findings (2 to 13 days after stroke) in all patients. Potential causes of stroke were assessed with the standard protocol of investigations of the Lausanne Stroke Registry. Stroke diagnosis was confirmed in all 100 patients and all 4 hemorrhages were diagnosed before CT/MRI. First-choice CDT (in 68) or second-choice CDT (in 20) was in agreement with CT/MRI in 88 patients. CDT was wrong in 4 patients and CT/MRI showed no lesion in 8 patients. First-choice CDE (in 70) or second-choice CDE (in 4) remained the most likely etiology in 74 patients, while the cause of stroke remained unknown in 24 patients. Thus, first- or second-choice CDT and CDE were confirmed in over 95% of the cases in which final diagnoses could be made. Our findings show that early CDT and CDE may be extremely accurate, and suggest that in acute stroke trials, investigations may not be compulsory for subgroup allocation before randomization.

Keywords:
Clinical examination, Stroke types, Cerebral infarct, Stroke etiology
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.